Viewing Study NCT01024894


Ignite Creation Date: 2025-12-25 @ 1:39 AM
Ignite Modification Date: 2026-05-21 @ 9:24 PM
Study NCT ID: NCT01024894
Status: UNKNOWN
Last Update Posted: 2012-10-18
First Post: 2009-12-02
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Dose Escalation Study of Interleukin-7 (IL-7) and Bitherapy in Asiatic HCV Patients Resistant to Bitherapy
Sponsor: Cytheris SA
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Hepatitis C View
Keywords:

Keywords

Keyword Brief Keyword Text View
None interleukin-7 View
None immune-based therapies View
None hepatitis C View
None chronic hepatitis View
None resistance to Peg-interferon and ribavirin bitherapy View
None immune specific responses to HCV View
None taiwan View
None phase 1/2a View
None viral disease View
None liver disease View